Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitized Brown Norway rats

被引:26
作者
Hannon, JP
Tigani, B
Wolber, C
Williams, I
Mazzoni, L
Howes, C
Fozard, JR [1 ]
机构
[1] Novartis Pharma AG, Res Dept, CH-4002 Basel, Switzerland
[2] Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England
关键词
adenosine receptors; airway hyperresponsiveness; allergen challenge; Brown Norway rat; lung parenchymal strip;
D O I
10.1038/sj.bjp.0704516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The bronchoconstrictor response to adenosine is markedly and selectively increased following ovalbumin (OA) challenge in actively sensitized, Brown Norway rats. We present a pharmacological analysis of the receptor mediating this response. 2 Like adenosine, the broad-spectrum adenosine receptor agonist, NECA, induced dose-related bronchoconstriction in actively sensitized, OA-challenged animals. In contrast, CPA, CGS 21680 and 2-Cl-IB-MECA, agonists selective for A(1) A(2A) and A(3) receptors, respectively, induced no, or minimal, bronchoconstriction. 3 Neither the selective A(1) receptor antagonist, DPCPX, nor the selective A(2A) receptor antagonist, ZM 241385, blocked the bronchoconstrictor response to adenosine. 4 MRS 1754, which has similar affinity for rat A(2B) and A(1) receptors, failed to block the bronchoconstrictor response to adenosine despite blockade of the A(1) receptor-mediated bradycardia induced by NECA. 5 8-SPT and CGS 15943, antagonists at A(1), A(2A), and A(2B) but not A(3) receptors, inhibited the bronchoconstrictor response to adenosine. However, the degree of blockade (approximately 3 fold) did not reflect the plasma concentrations, which were 139 and 21 times greater than the K-B value at the rat A(2B) receptor, respectively. 6 Adenosine and NECA, but not CPA, CGS 21680 or 2-Cl-IB-MECA, induced contraction of parenchymal strip preparations from actively sensitized OA-challenged animals. Responses to adenosine could not be antagonized by 8-SPT or MRS 1754 at concentrations >50 times their affinities at the rat A(2B) receptor. 7 The receptor mediating the bronchoconstrictor response to adenosine augmented following allergen challenge in actively sensitized BN rats cannot be categorized as one of the four recognized adenosine receptor subtypes.
引用
收藏
页码:685 / 696
页数:12
相关论文
共 41 条
[1]   EFFECTS OF PURINES ON THE LONGITUDINAL MUSCLE OF THE RAT COLON [J].
BAILEY, SJ ;
HOURANI, SMO .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :885-892
[2]  
BALWIERCZAK JL, 1989, J PHARMACOL EXP THER, V251, P279
[3]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[4]   BINDING OF THE A1-SELECTIVE ADENOSINE ANTAGONIST 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE TO RAT-BRAIN MEMBRANES [J].
BRUNS, RF ;
FERGUS, JH ;
BADGER, EW ;
BRISTOL, JA ;
SANTAY, LA ;
HARTMAN, JD ;
HAYS, SJ ;
HUANG, CC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (01) :59-63
[5]   Adenosine A2B receptors:: a novel therapeutic target in asthma? [J].
Feoktistov, I ;
Polosa, R ;
Holgate, ST ;
Biaggioni, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (04) :148-153
[6]   Adenosine, mast cells and asthma [J].
Forsythe, P ;
Ennis, M .
INFLAMMATION RESEARCH, 1999, 48 (06) :301-307
[7]  
Fozard JR, 2000, CLIN EXP ALLERGY, V30, P1213
[8]  
FOZARD JR, 1993, N-S ARCH PHARMACOL, V347, P192
[9]   Adenosine receptor ligands: Potential as therapeutic agents in asthma and COPD [J].
Fozard, JR ;
Hannon, JP .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (02) :111-114
[10]   Mast cell degranulation following adenosine A(3) receptor activation in rats [J].
Fozard, JR ;
Pfannkuche, HJ ;
Schuurman, HJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (03) :293-297